8-K filing — Tectonic Therapeutic, Inc. (TECX)
Filed: 2026-09-29 AccNo: 0001193125-26-407823 Size: 171 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Stocks · News reference
UBS Initiates Coverage On Tectonic Therapeutic with Neutral Rating, Announces Price Target of $26
UBS analyst Alice Nettleton initiates coverage on Tectonic Therapeutic (NASDAQ:TECX) with a Neutral rating and announces Price Target of $26.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93
Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.
Tectonic Therapeutic Q2 EPS $(1.18) Beats $(1.37) Estimate
Tectonic Therapeutic (NASDAQ:TECX) reported quarterly losses of $(1.18) per share which beat the analyst consensus estimate of $(1.37) by 13.87 percent. This is a 10.28 percent decrease over losses of $(1.07) per share